MA
FOLD

MUFG Americas’s Amicus Therapeutics FOLD Stock Holding History

MUFG Americas’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-900
Closed -$14K – 771
2018
Q2 		$14K Hold
900
– – ﹤0.01% 724
2018
Q1 		$14K Sell
900
-280
-24% -$4.26K ﹤0.01% 719
2017
Q4 		$17K Buy
+1,180
New +$16.2K ﹤0.01% 773
2015
Q4 		– Sell
-700
Closed -$10K – 1114
2015
Q3 		$10K Buy
700
+70
+11% +$1.1K ﹤0.01% 854
2015
Q2 		$9K Sell
630
-5,760
-90% -$69.2K ﹤0.01% 877
2015
Q1 		$70K Buy
6,390
+1,350
+27% +$11.9K ﹤0.01% 601
2014
Q4 		$42K Buy
5,040
+2,000
+66% +$13.7K ﹤0.01% 697
2014
Q3 		$18K Buy
+3,040
New +$15.9K ﹤0.01% 834

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MUFG Americas's FOLD Position: Q3 2018 in Review

MUFG Americas sold out of Amicus Therapeutics (FOLD) in Q3 2018, closing a stake of 900 shares — an estimated $14K sold.

MUFG Americas first reported a position in FOLD in Q3 2014 and held it in 8 quarters. The position peaked at $70K in Q1 2015. 204 funds tracked by Wall St. Rank hold FOLD as of Q3 2018.

  • MUFG Americas reported no remaining Amicus Therapeutics position as of Q3 2018 after selling out during the quarter.
  • MUFG Americas sold 900 Amicus Therapeutics shares in Q3 2018, an estimated $14K.
  • MUFG Americas first reported a position in Amicus Therapeutics in Q3 2014 and held it in 8 quarters.
  • MUFG Americas's Amicus Therapeutics position peaked at $70K in Q1 2015.
  • 204 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2018.

Based on MUFG Americas's 13F filing for Q3 2018, filed 14 Nov 2018.